Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

| April 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD
Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina.

Innov Clin Neurosci. 2017;14(3–4):38–40

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , ,

Category: Commentary, Devices, Evaluations, Multiple Sclerosis, Neurology, Past Articles, Technology

Leave a Reply